Renaissance Technologies’s Acer Therapeutics Inc ACER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-102,552
Closed -$95K 4258
2023
Q2
$95K Sell
102,552
-9,248
-8% -$8.2K ﹤0.01% 3488
2023
Q1
$85K Buy
111,800
+53,300
+91% +$105K ﹤0.01% 3538
2022
Q4
$147K Sell
58,500
-9,100
-13% -$15.6K ﹤0.01% 3516
2022
Q3
$94K Sell
67,600
-2,100
-3% -$3.04K ﹤0.01% 3620
2022
Q2
$88K Buy
69,700
+47,700
+217% +$99.9K ﹤0.01% 3881
2022
Q1
$64K Buy
22,000
+4,600
+26% +$11.1K ﹤0.01% 3870
2021
Q4
$40K Buy
+17,400
New +$40.4K ﹤0.01% 3801
2018
Q4
Sell
-11,235
Closed -$346K 3688
2018
Q3
$346K Buy
+11,235
New +$301K ﹤0.01% 2972
2017
Q1
Sell
-1,085
Closed -$10K 3463
2016
Q4
$10K Sell
1,085
-17,989
-94% -$315K ﹤0.01% 3213
2016
Q3
$630K Buy
19,074
+2,841
+18% +$119K ﹤0.01% 2745
2016
Q2
$698K Buy
16,233
+2,007
+14% +$59.7K ﹤0.01% 2671
2016
Q1
$344K Buy
14,226
+1,238
+10% +$27.1K ﹤0.01% 2953
2015
Q4
$375K Buy
12,988
+5,559
+75% +$184K ﹤0.01% 2820
2015
Q3
$242K Buy
7,429
+2,977
+67% +$105K ﹤0.01% 2852
2015
Q2
$165K Buy
+4,452
New +$171K ﹤0.01% 3019

Other funds holding ACER

Renaissance Technologies's ACER Position: Q3 2023 in Review

Renaissance Technologies sold out of Acer Therapeutics Inc (ACER) in Q3 2023, closing a stake of 102,552 shares — an estimated $95K sold.

Renaissance Technologies first reported a position in ACER in Q2 2015 and held it in 15 quarters. The position peaked at $698K in Q2 2016. 31 funds tracked by Wall St. Rank hold ACER as of Q3 2023.

  • Renaissance Technologies reported no remaining Acer Therapeutics Inc position as of Q3 2023 after selling out during the quarter.
  • Renaissance Technologies sold 102,552 Acer Therapeutics Inc shares in Q3 2023, an estimated $95K.
  • Renaissance Technologies first reported a position in Acer Therapeutics Inc in Q2 2015 and held it in 15 quarters.
  • Renaissance Technologies's Acer Therapeutics Inc position peaked at $698K in Q2 2016.
  • 31 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q3 2023.

Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.